Functional Psychiatry: Ketamine, Psilocybin, MDMA, and Treatment-Resistant Depression
Quick answer: Functional psychiatry integrates evidence-based psychedelic-assisted therapy, nutritional psychiatry, and neurobiological optimization to address treatment-resistant mental illness—ketamine produces rapid antidepressant response in 70% of treatment-resistant patients within hours (Murrough 2013, NEJM, n=73), psilocybin-assisted therapy achieves 71% depression response at 4 weeks (Davis 2021, JAMA Psychiatry, n=24), and MDMA-assisted therapy produces PTSD remission in 67% … Read more